Update on chemotherapy of renal tuberculosis.
A 5-year experience is presented with a new regimen for renal tuberculosis, consisting of isoniazid, ethambutol and rifampin. This regimen has proved satisfactory to date and compares favorably to previous regimens. A plea for long-term therapy is made until further study of short-term treatment proves it to be free of recurrences.
D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D008875:Middle Aged; D011736:Pyridoxine / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D013997:Time Factors; D014398:Tuberculosis, Renal / Q000188:drug therapy*
D000995:Antitubercular Agents; D004977:Ethambutol; D011736:Pyridoxine; D007538:Isoniazid; D012293:Rifampin